Bromide

Bromide

SCHEMBL52254

CC(=O)OCCCCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 2/20 0.47
CHRNA7 P36544 7/20 0.47
ALDH1A1 P00352 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
PTGS2 P35354 1/20 0.45
HIF1A Q16665 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL11352069 1.00 TRAP1 (0.47) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL28914657 0.94 ALDH1A1 (0.49) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL15916470 0.84 TRAP1 (0.44) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL26905302 0.82 ALDH1A1 (0.44) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL4895935 0.82 TDP1 (0.51) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL20874269 0.82 CHRNA7 (0.48) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL20874314 0.82 CHRNA7 (0.48) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL29057269 0.81 TSHR (0.54) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL20874396 0.80 CHRNA7 (0.47) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL30082511 0.79 TDP1 (0.48) TRAP1CHRNA7ALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129552-B2 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2012-03-06 US disclosed
US-20080214849-A1 PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSHAFTEN E.V. (DE) 2008-09-04 US disclosed
EP-1102775-B1 NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS MAX PLANCK GESELLSCHAFT (DE) 2005-06-08 EP disclosed
EP-1102775-A1 NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2001-05-30 EP disclosed
WO-2000008031-A1 NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2000-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214849-A1 PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS PHOSPHO1, PLTP, SGMS1 TRAP1 1259/4885CHRNA7 4429/4885ALDH1A1 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.